Arkolith/Insider Trading/KBPH/Form 4

Benarroch Georges

DirectorKyto Technology & Life Science, Inc. (KBPH) · full profile →Form 4 · filed Apr 14, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2021Option exercise(M)181K$0.03$5K181K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 16, 2021Option exercise(M)181K$0.03$5K19K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001051339-21-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML